Stock Market

Canadian marijuana producer and processor Tilray (NASDAQ:TLRY) made history in July 2018 when it became the first pure-play cannabis company to trade publicly on a major U.S. exchange. Just three months later, the Canadian government legalized marijuana for recreational purposes, in addition to the already legalized medical use. TLRY stock, which went public at $17
0 Comments
If special purpose acquisition companies have jumped the shark, they may have done so with Digital World Acquisition (NASDAQ:DWAC). The so-called Trump special purpose acquisition company (SPAC), Digital World is the blank-check firm that will take the former president’s media firm Trump Media & Technology Group (TMTG) public. Undergirding DWAC stock is the much-eyeballed social
0 Comments
Microsoft (NASDAQ:MSFT) stock once again represents the world’s most valuable company, ahead of Apple (NASDAQ:AAPL). Source: NYCStock / Shutterstock.com Some charge it’s also the most overvalued one. It’s not. At its current price of $336, Microsoft has a market cap of $2.5 trillion. More important, investors are paying 37.5x earnings for MSFT stock and taking
0 Comments
It would be fresh in investors memory that Lucid (NASDAQ:LCID) stock surged from below $10 to highs of $64.86. This happened even before the special purpose acquisition company (SPACs) became announced publicly. After the announcement, LCID stock slumped to lows of $20. It’s a perfect example of investors selling on news and I believe that Ocugen
0 Comments
Clover Health Investments (NASDAQ:CLOV) has been one of the year’s bigger disappointments. Other than a couple of days when CLOV stock was lifted by a short squeeze in June, the shares have been almost unrelentingly trending downward. With the latest decline, Clover’s shares are now down more than 50% in 2021. Source: Shutterstock This was
0 Comments
AMC Entertainment (NYSE:AMC) is making news again. For most of 2021, that has been a signal to the loyal AMC shareholders to send the stock to the moon. However, so far it looks like AMC stock is remaining relatively tame. That seems reasonable to me, but I’ll let you decide.   Source: Helen89 / Shutterstock.com On Nov. 1,
0 Comments
Early in October, I said that Cassava Sciences’ (NASDAQ:SAVA) big gains in late September had investors dreaming of a big payday for SAVA stock in 2022.  Source: Pavel Kapysh / Shutterstock.com I even suggested it might retest $100—a level it hit throughout the summer—by the end of 2021. I was convinced it would go on
0 Comments